SELLAS Life Sciences Group, Inc. (SLS)

5.28 -0.26 (-4.69%) USD  |  NASDAQ  |  Mar 05, 16:00
5.24 -0.04 (-0.76%) After-Hours: 05:07
More

SELLAS Life Sciences Group Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade